Health & Biotech
Health & Biotech
Check Up: Eco-fibre play Nanollose leads ASX healthcare sector with 292% gain
Health & Biotech
Weed Week: US cannabis shop gives new meaning to the term ‘pot shots’
Health & Biotech
Rhythm keeps flying after validating prototype commercial test-kits
Health & Biotech
Botanix collab with UQ confirms antimicrobial potential of CBD
Health & Biotech
3 cannabis players discuss how to view the sector through a biotech lens
Health & Biotech
Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platform
Health & Biotech
Skin Elements ready to launch ‘game changing’ anti-COVID disinfectant range
Health & Biotech
Creso Pharma experiencing strong demand for pet-health cannabis products
Health & Biotech
Dr Boreham’s Crucible: Do these mobile X-ray deals have Micro-X primed to explode?
Health & Biotech
Neuroscientific is researching a potential cure for post-COVID lung damage
Health & Biotech
Orthocell jumps again after dental membrane approved in USA
Health & Biotech
Omni Innovation gets green light for multi-country distribution deal
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
Health & Biotech
Creso Pharma books another cannaQIX order in South Africa, as cash stockpile soars
Health & Biotech
Eve Investment’s Meluka Australia honey added to Whole Foods product range in the US
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.